173 related articles for article (PubMed ID: 37568816)
1. Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats.
Madka V; Patlolla JMR; Venkatachalam K; Zhang Y; Pathuri G; Stratton N; Lightfoot S; Janakiram NB; Mohammed A; Rao CV
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568816
[TBL] [Abstract][Full Text] [Related]
2. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV
Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
[TBL] [Abstract][Full Text] [Related]
6. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
[TBL] [Abstract][Full Text] [Related]
8. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
Mackenzie GG; Ouyang N; Xie G; Vrankova K; Huang L; Sun Y; Komninou D; Kopelovich L; Rigas B
Cancer Prev Res (Phila); 2011 Jul; 4(7):1052-60. PubMed ID: 21464038
[TBL] [Abstract][Full Text] [Related]
9. Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer.
Janakiram NB; Mohammed A; Bryant T; Zhang Y; Brewer M; Duff A; Biddick L; Singh A; Lightfoot S; Steele VE; Rao CV
Sci Rep; 2016 Nov; 6():37046. PubMed ID: 27841323
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis.
Reddy BS; Kawamori T; Lubet R; Steele V; Kelloff G; Rao CV
Carcinogenesis; 1999 Aug; 20(8):1645-8. PubMed ID: 10426822
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
[TBL] [Abstract][Full Text] [Related]
12. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
Singh J; Kulkarni N; Kelloff G; Reddy BS
Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306
[TBL] [Abstract][Full Text] [Related]
13. Effect of chemopreventive agents on posttranslational plasmamembrane association of ras-p21 during chemoprevention of azoxymethane-induced colon carcinogenesis.
Singh J; Reddy B
Int J Oncol; 1995 Feb; 6(2):301-6. PubMed ID: 21556537
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
16. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis.
Singh J; Kelloff G; Reddy BS
Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Rao CV; Reddy BS; Steele VE; Wang CX; Liu X; Ouyang N; Patlolla JM; Simi B; Kopelovich L; Rigas B
Mol Cancer Ther; 2006 Jun; 5(6):1530-8. PubMed ID: 16818512
[TBL] [Abstract][Full Text] [Related]
18. Effect of the chemopreventive agents piroxicam and D,L-alpha-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis.
Kulkarni N; Zang E; Kelloff G; Reddy BS
Carcinogenesis; 1992 Jun; 13(6):995-1000. PubMed ID: 1600622
[TBL] [Abstract][Full Text] [Related]
19. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents.
Tao L; Kramer PM; Wang W; Yang S; Lubet RA; Steele VE; Pereira MA
Carcinogenesis; 2002 Sep; 23(9):1447-54. PubMed ID: 12189186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
